Immad and Raj sit down with Celine Halioua, founder and CEO of Loyal, a pioneering biotech company developing drugs to increase lifespan longevity in dogs. This episode highlights the unique challenges of building a biotech company, from navigating FDA approval processes to explaining longevity science to investors. The conversation also explores alternative funding sources beyond traditional VC, with all three founders sharing war stories about their toughest fundraising experiences. Whether you're interested in biotech, startup fundraising, or the future of longevity research, this conversation offers valuable insights into building innovative companies without relying on the typical Silicon Valley playbook.

Want to join the conversation? Connect with us on Tribe:

https://trbcht.com/invites/WmHNjar5ZN